| Prognostic Role of KRAS and BRAF in Stage II and III Resected Colon Cancer: Results of the Translational Study on the PETACC-3, EORTC 40993, SAKK 60-00 … AD Roth, S Tejpar, M Delorenzi, P Yan, R Fiocca, D Klingbiel, D Dietrich, ... Journal of clinical oncology 28 (3), 466-474, 2010 | 1038 | 2010 |
| Distal and proximal colon cancers differ in terms of molecular, pathological, and clinical features E Missiaglia, B Jacobs, G D'ario, AF Di Narzo, C Soneson, E Budinska, ... Annals of oncology 25 (10), 1995-2001, 2014 | 352 | 2014 |
| Integrated analysis of molecular and clinical prognostic factors in stage II/III colon cancer AD Roth, M Delorenzi, S Tejpar, P Yan, D Klingbiel, R Fiocca, G d’Ario, ... Journal of the National Cancer Institute 104 (21), 1635-1646, 2012 | 200 | 2012 |
| Prognosis of stage II and III colon cancer treated with adjuvant 5-fluorouracil or FOLFIRI in relation to microsatellite status: results of the PETACC-3 trial D Klingbiel, Z Saridaki, AD Roth, FT Bosman, M Delorenzi, S Tejpar Annals of oncology 26 (1), 126-132, 2015 | 125 | 2015 |
| Microsatellite instability (MSI) in stage II and III colon cancer treated with 5FU-LV or 5FU-LV and irinotecan (PETACC 3-EORTC 40993-SAKK 60/00 trial) S Tejpar, F Bosman, M Delorenzi, R Fiocca, P Yan, D Klingbiel, D Dietrich, ... Journal of Clinical Oncology 27 (15_suppl), 4001-4001, 2009 | 122 | 2009 |
| Phase 2 trial of single-agent everolimus in chemotherapy-naive patients with castration-resistant prostate cancer (SAKK 08/08) AJ Templeton, V Dutoit, R Cathomas, C Rothermundt, D Bärtschi, ... European urology 64 (1), 150-158, 2013 | 107 | 2013 |
| Expression profiling of human idiopathic dilated cardiomyopathy R Grzeskowiak, H Witt, M Drungowski, R Thermann, S Hennig, A Perrot, ... Cardiovascular research 59 (2), 400-411, 2003 | 102 | 2003 |
| Final results of a prospective evaluation of the predictive value of interim positron emission tomography in patients with diffuse large B-cell lymphoma treated with R-CHOP-14 … C Mamot, D Klingbiel, F Hitz, C Renner, T Pabst, C Driessen, U Mey, ... Journal of clinical oncology 33 (23), 2523-2529, 2015 | 101 | 2015 |
| A multicenter phase II trial (SAKK 36/06) of single-agent everolimus (RAD001) in patients with relapsed or refractory mantle cell lymphoma C Renner, PL Zinzani, R Gressin, D Klingbiel, PY Dietrich, F Hitz, ... Haematologica 97 (7), 1085-1091, 2012 | 93 | 2012 |
| Hyperthermia and radiation therapy in locoregional recurrent breast cancers: a systematic review and meta-analysis NR Datta, E Puric, D Klingbiel, S Gomez, S Bodis International Journal of Radiation Oncology* Biology* Physics 94 (5), 1073-1087, 2016 | 88 | 2016 |
| Outcome, quality of life and cognitive function of patients with brain metastases from non-small cell lung cancer treated with whole brain radiotherapy combined with gefitinib … GA Pesce, D Klingbiel, K Ribi, A Zouhair, R Von Moos, M Schlaeppi, ... European journal of cancer 48 (3), 377-384, 2012 | 88 | 2012 |
| A cost-effectiveness analysis of nivolumab versus docetaxel for advanced nonsquamous NSCLC including PD-L1 testing K Matter-Walstra, M Schwenkglenks, S Aebi, K Dedes, J Diebold, ... Journal of Thoracic Oncology 11 (11), 1846-1855, 2016 | 72 | 2016 |
| Prognostic role of KRAS and BRAF in stage II and III resected colon cancer: results of the translational study on the PETACC-3, EORTC 40993, SAKK 60-00 trial. 2010 AD Roth, S Tejpar, M Delorenzi, P Yan, R Fiocca, D Klingbiel J Clin Oncol. Jan 20 (28), 3, 0 | 65 | |
| Prognostic impact of deficient mismatch repair (dMMR) in 7,803 stage II/III colon cancer (CC) patients (pts): A pooled individual pt data analysis of 17 adjuvant trials in the … DJ Sargent, Q Shi, G Yothers, S Tejpar, MM Bertagnolli, SN Thibodeau, ... Journal of Clinical Oncology 32 (15_suppl), 3507-3507, 2014 | 64 | 2014 |
| The effect of real-time electronic monitoring of patient-reported symptoms and clinical syndromes in outpatient workflow of medical oncologists: E-MOSAIC, a … F Strasser, D Blum, R Von Moos, R Cathomas, K Ribi, S Aebi, D Betticher, ... Annals of Oncology 27 (2), 324-332, 2016 | 55 | 2016 |
| Hyperthermia and radiotherapy with or without chemotherapy in locally advanced cervical cancer: a systematic review with conventional and network meta-analyses NR Datta, S Rogers, D Klingbiel, S Gómez, E Puric, S Bodis International Journal of Hyperthermia 32 (7), 809-821, 2016 | 51 | 2016 |
| Concurrent chemoradiotherapy vs. radiotherapy alone in locally advanced cervix cancer: a systematic review and meta-analysis NR Datta, E Stutz, M Liu, S Rogers, D Klingbiel, A Siebenhüner, S Singh, ... Gynecologic Oncology 145 (2), 374-385, 2017 | 47 | 2017 |
| Circulating microRNA profiling in patients with advanced non-squamous NSCLC receiving bevacizumab/erlotinib followed by platinum-based chemotherapy at progression (SAKK 19/05) M Joerger, F Baty, M Früh, C Droege, RA Stahel, DC Betticher, ... Lung Cancer 85 (2), 306-313, 2014 | 36 | 2014 |
| Standardization for Ki-67 assessment in moderately differentiated breast cancer. A retrospective analysis of the SAKK 28/12 study Z Varga, E Cassoly, Q Li, C Oehlschlegel, C Tapia, HA Lehr, D Klingbiel, ... PLoS One 10 (4), e0123435, 2015 | 35 | 2015 |
| Efficacy of cetuximab in metastatic castration-resistant prostate cancer might depend on EGFR and PTEN expression: results from a phase II trial (SAKK 08/07) R Cathomas, C Rothermundt, D Klingbiel, L Bubendorf, R Jaggi, ... Clinical cancer research 18 (21), 6049-6057, 2012 | 34 | 2012 |
Mauro DelorenziSIB Swiss Institute of BioinformaticsVerified email at unil.ch
